Drug Discovery Europe 2026, Berlin
Meet Nygen at Drug Discovery Europe 2026 in Berlin, June 15 to 16. Find us in the Data and AI Zone for conversations on single-cell analytics and AI for drug discovery.
Conference overview
Drug Discovery Europe 2026 is part of Discovery & Development Europe, a two-day gathering of 1,000+ senior leaders from pharma, biotech, academia, and technology organisations at the Estrel Congress Centre in Berlin.
The Drug Discovery programme explores how AI, advanced biology, and translational science are reshaping the earliest stages of the pipeline: target identification, computational chemistry, targeted protein degradation, ADC development, lab automation, and neuroscience drug development. The wider event also includes co-located Formulation and Delivery and Neuroscience Drug Development programmes, an AI and Digitisation Zone, keynotes, roundtables, and 400+ pre-arranged one-to-one meetings.
Dates: June 15 and 16, 2026.
Venue
Estrel Congress Centre
Sonnenallee 225, 12057 Berlin, Germany
Travel and venue details are on the official event page.
Nygen at Drug Discovery Europe
Meet us in the Data and AI Zone. Nygen will be on the exhibition floor for conversations on single-cell analytics, evidence-based cell type annotation, and how discovery teams are embedding AI into target and translational workflows.
Parashar Dhapola, PhD, CEO, will be on site. Stop by the Data and AI Zone or reach out in advance to book time.
Meet our team
To pre-book a meeting during the conference, email parashar.dhapola@nygen.io and we will confirm a slot that fits your agenda.
Registration
Delegate registration and the full programme are on the Discovery & Development Europe site.
